3Griffiths CE,Barker JN.Pathogenesis and clinical features of psoriasis[J].Lancet,2007,370(9583):263-271.
4Gisondi P,Tessari G,Conti A,et al.Prevalence of metabolic syndrome in patients with psoriasis:a hospital-based case-control study[J].Br J Dermatol,2007,157(1):68-73.
5Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)[J].JAMA,285(19):2486-2497.
6The World Health Organization Western Pacific Region,the International Association for the Study of Obesity,and the International Obesity Task Force.The Asia-Pacific perspective:redefining obesity and its treatment[M].Melbourne:Health Communications Australia,2000.
7Sommer DM,Jenisch S,Suchan M,et al.Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis[J].Arch Dermatol Res,2006,298(7):321-328.
8Cohen AD,Sherf M,Vidavsky L,et al.Association between psoriasis and the metabolic syndrome.A cross-sectional study[J].Dermatology,2008,216(2):152-155.
9Mallbris L,Granath F,Hamsten A,et al.Psoriasis is associated with lipid abnormalities at the onset of skin disease[J].J Am Acad Dermatol,2006,54(4):614-621.
10Gu D,Reynolds K,Wu X,et al.Prevalence of the metabolic syndrome and overweight among adults in China[J].Lancet,2005,365(9468):1398-1405.
